O	3	6	Ten
O	6	7	-
O	7	11	year
O	12	21	incidence
O	22	25	and
O	26	37	progression
O	38	40	of
B-Disease	41	44	age
I-Disease	44	45	-
I-Disease	45	52	related
I-Disease	53	64	maculopathy
O	64	65	:
O	66	69	the
O	70	74	blue
O	75	84	Mountains
O	85	88	Eye
O	89	94	Study

O	96	103	Purpose
O	103	104	:
O	105	107	To
O	108	114	assess
O	115	118	the
O	119	121	10
O	121	122	-
O	122	126	year
O	127	136	incidence
O	137	139	of
B-Disease	140	143	age
I-Disease	143	144	-
I-Disease	144	151	related
I-Disease	152	163	maculopathy
O	164	165	(
B-Disease	165	168	ARM
O	168	169	)
O	170	172	in
O	173	175	an
B-Characteristic	176	181	older
I-Characteristic	182	192	Australian
I-Characteristic	193	199	cohort
O	199	200	.

O	202	208	Design
O	208	209	:
O	210	220	Population
O	220	221	-
O	221	226	based
O	227	233	cohort
O	234	239	study
O	239	240	.

O	242	254	Participants
O	254	255	:
O	256	261	Three
O	262	270	thousand
O	271	274	six
O	275	282	hundred
O	283	288	fifty
O	288	289	-
O	289	293	four
O	294	298	Blue
O	299	308	Mountains
O	309	312	Eye
O	313	318	Study
O	319	331	participants
B-Characteristic	332	333	>
I-Characteristic	334	336	or
I-Characteristic	337	338	=
I-Characteristic	338	340	49
I-Characteristic	341	346	years
I-Characteristic	347	350	old
O	351	355	were
O	356	364	examined
O	365	371	during
O	372	376	1992
O	377	384	through
O	385	389	1994
O	389	390	;
O	391	395	2335
O	396	397	(
O	397	399	75
O	399	400	%
O	401	403	of
O	404	413	survivors
O	413	414	)
O	415	419	were
O	420	430	reexamined
O	431	436	after
O	437	438	5
O	439	444	years
O	445	446	(
O	446	450	1997
O	450	451	-
O	451	455	1999
O	455	456	)
O	457	460	and
O	461	465	1952
O	466	467	(
O	467	469	76
O	469	470	%
O	471	473	of
O	474	483	survivors
O	483	484	)
O	485	490	after
O	491	493	10
O	494	499	years
O	500	501	(
O	501	505	2002
O	505	506	-
O	506	510	2004
O	510	511	)
O	511	512	.

O	514	521	Methods
O	521	522	:
O	523	526	The
O	527	531	same
O	532	539	graders
O	540	549	performed
B-Diagnostic_tool	550	557	retinal
I-Diagnostic_tool	558	570	photographic
I-Diagnostic_tool	571	578	grading
O	579	581	in
O	582	585	all
O	586	598	examinations
O	598	599	,
O	600	605	using
O	606	609	the
B-Classification_system	610	619	Wisconsin
I-Classification_system	620	623	Age
I-Classification_system	623	624	-
I-Classification_system	624	631	Related
I-Classification_system	632	643	Maculopathy
I-Classification_system	644	651	Grading
O	652	658	System
O	658	659	.

B-Diagnostic_tool	660	671	Photographs
O	672	674	of
O	675	687	participants
O	688	692	with
B-Symptom	693	696	ARM
I-Symptom	697	704	lesions
O	705	707	at
O	708	711	any
O	712	714	of
O	715	718	the
O	719	731	examinations
O	732	736	were
O	737	749	subsequently
O	750	758	regraded
O	759	764	using
O	765	766	a
O	767	771	side
O	771	772	-
O	772	774	by
O	774	775	-
O	775	779	side
O	780	790	comparison
O	791	797	method
O	797	798	.

O	800	804	Main
O	805	812	outcome
O	813	821	measures
O	821	822	:
O	823	826	The
O	827	836	diagnosis
O	837	839	of
B-Disease	840	848	incident
I-Disease	849	853	late
I-Disease	854	857	ARM
O	858	861	was
O	862	867	given
O	868	870	if
B-Symptom	871	882	neovascular
I-Symptom	883	886	ARM
O	887	889	or
B-Symptom	890	900	geographic
I-Symptom	901	908	atrophy
O	909	912	was
O	913	921	detected
O	922	924	at
O	925	931	either
O	932	938	follow
O	938	939	-
O	939	941	up
O	942	953	examination
O	954	956	in
O	957	964	persons
O	965	969	free
O	970	972	of
O	973	978	these
O	979	986	lesions
O	987	989	at
O	990	998	baseline
O	998	999	.

B-Disease	1000	1008	Incident
I-Disease	1009	1014	early
I-Disease	1015	1018	ARM
O	1019	1022	was
O	1023	1032	diagnosed
O	1033	1035	if
B-Disease	1036	1041	early
I-Disease	1042	1045	ARM
O	1046	1047	(
B-Symptom	1047	1051	soft
I-Symptom	1052	1062	indistinct
I-Symptom	1063	1065	or
I-Symptom	1066	1075	reticular
I-Symptom	1076	1082	drusen
O	1083	1085	or
B-Symptom	1086	1094	combined
I-Symptom	1095	1099	soft
I-Symptom	1100	1108	distinct
I-Symptom	1109	1115	drusen
I-Symptom	1116	1119	and
I-Symptom	1120	1127	retinal
I-Symptom	1128	1135	pigment
I-Symptom	1136	1147	abnormality
O	1147	1148	)
O	1149	1152	was
O	1153	1160	present
O	1161	1163	in
O	1164	1171	persons
O	1172	1176	free
O	1177	1179	of
B-Disease	1180	1185	early
I-Disease	1186	1189	and
I-Disease	1190	1194	late
I-Disease	1195	1198	ARM
O	1199	1201	at
O	1202	1210	baseline
O	1210	1211	.

B-Disease	1212	1215	Age
I-Disease	1215	1216	-
I-Disease	1216	1223	related
I-Disease	1224	1235	maculopathy
O	1236	1245	incidence
O	1246	1249	was
O	1250	1260	calculated
O	1261	1266	using
O	1267	1273	Kaplan
O	1273	1274	-
O	1274	1279	Meier
O	1280	1287	methods
O	1288	1290	to
O	1291	1302	incorporate
O	1303	1314	information
O	1315	1319	from
O	1320	1324	both
O	1325	1326	5
O	1326	1327	-
O	1328	1331	and
O	1332	1334	10
O	1334	1335	-
O	1335	1339	year
O	1340	1352	examinations
O	1352	1353	.

O	1354	1362	Discrete
O	1363	1371	logistic
O	1372	1378	models
O	1379	1383	were
O	1384	1388	used
O	1389	1391	to
O	1392	1398	assess
O	1399	1402	the
O	1403	1407	risk
O	1408	1410	of
B-Disease	1411	1419	incident
I-Disease	1420	1424	late
I-Disease	1425	1428	ARM
O	1429	1438	according
O	1439	1441	to
O	1442	1449	various
O	1450	1458	baseline
O	1459	1466	factors
O	1466	1467	,
O	1468	1477	including
B-Symptom	1478	1483	early
I-Symptom	1484	1487	ARM
I-Symptom	1488	1494	lesion
O	1495	1510	characteristics
O	1510	1511	.

O	1513	1520	Results
O	1520	1521	:
O	1522	1527	After
O	1528	1537	excluding
O	1538	1540	72
B-Disease	1541	1545	late
I-Disease	1546	1549	ARM
O	1550	1555	cases
O	1556	1563	present
O	1564	1566	at
O	1567	1575	baseline
O	1575	1576	,
O	1577	1581	2395
O	1582	1584	of
O	1585	1589	3582
O	1590	1598	subjects
O	1599	1601	at
O	1602	1606	risk
O	1607	1609	of
B-Disease	1610	1614	late
I-Disease	1615	1618	ARM
O	1619	1620	(
O	1620	1622	67
O	1622	1623	%
O	1623	1624	)
O	1625	1629	were
O	1630	1640	reexamined
O	1641	1643	at
O	1644	1650	either
O	1651	1657	follow
O	1657	1658	-
O	1658	1660	up
O	1661	1665	time
O	1666	1671	point
O	1672	1674	or
O	1675	1679	both
O	1680	1686	follow
O	1686	1687	-
O	1687	1689	up
O	1690	1694	time
O	1695	1701	points
O	1701	1702	.

O	1703	1707	Over
O	1708	1711	the
O	1712	1714	10
O	1714	1715	-
O	1715	1719	year
O	1720	1726	period
O	1726	1727	,
O	1728	1730	72
O	1731	1733	of
O	1734	1738	2395
O	1739	1747	subjects
O	1748	1749	(
O	1749	1750	3
O	1750	1751	.
O	1751	1752	7
O	1752	1753	%
O	1753	1754	)
O	1755	1764	developed
B-Disease	1765	1769	late
I-Disease	1770	1773	ARM
O	1774	1777	and
O	1778	1781	266
O	1782	1784	of
O	1785	1789	2255
O	1790	1798	subjects
O	1799	1800	(
O	1800	1802	14
O	1802	1803	.
O	1803	1804	1
O	1804	1805	%
O	1805	1806	)
O	1807	1816	developed
B-Disease	1817	1822	early
I-Disease	1823	1826	ARM
O	1826	1827	.

O	1828	1833	After
O	1834	1837	age
O	1838	1853	standardization
O	1854	1856	to
O	1857	1860	the
O	1861	1867	Beaver
O	1868	1871	Dam
O	1872	1875	Eye
O	1876	1881	Study
O	1882	1892	population
O	1892	1893	,
O	1894	1897	our
O	1898	1900	10
O	1900	1901	-
O	1901	1905	year
O	1906	1916	incidences
O	1917	1919	of
B-Disease	1920	1924	late
I-Disease	1925	1928	and
I-Disease	1929	1934	early
I-Disease	1935	1938	ARM
O	1939	1943	were
O	1944	1945	2
O	1945	1946	.
O	1946	1947	8
O	1947	1948	%
O	1949	1952	and
O	1953	1955	10
O	1955	1956	.
O	1956	1957	8
O	1957	1958	%
O	1958	1959	,
O	1960	1972	respectively
O	1972	1973	.

O	1974	1982	Baseline
B-Characteristic	1983	1986	age
O	1987	1990	and
B-Symptom	1991	1996	early
I-Symptom	1997	2000	ARM
I-Symptom	2001	2007	lesion
O	2008	2023	characteristics
O	2024	2027	and
O	2028	2036	severity
O	2037	2041	were
O	2042	2048	strong
O	2049	2059	predictors
O	2060	2062	of
B-Disease	2063	2067	late
I-Disease	2068	2071	ARM
O	2072	2081	incidence
O	2081	2082	.

O	2084	2095	Conclusions
O	2095	2096	:
O	2097	2101	Long
O	2101	2102	-
O	2102	2106	term
O	2107	2113	follow
O	2113	2114	-
O	2114	2116	up
O	2117	2119	of
O	2120	2124	this
B-Characteristic	2125	2130	older
I-Characteristic	2131	2141	population
O	2142	2150	confirms
O	2151	2155	that
O	2156	2159	the
O	2160	2164	risk
O	2165	2167	of
B-Disease	2168	2171	ARM
O	2172	2183	progression
O	2184	2186	is
O	2187	2194	related
O	2195	2203	strongly
O	2204	2206	to
O	2207	2210	the
O	2211	2219	severity
O	2220	2222	of
B-Symptom	2223	2228	early
I-Symptom	2228	2229	-
I-Symptom	2229	2234	stage
I-Symptom	2235	2242	lesions
O	2242	2243	.

O	2244	2247	The
O	2248	2253	study
O	2254	2262	provides
O	2263	2271	evidence
O	2271	2272	-
O	2272	2277	based
O	2278	2286	criteria
O	2287	2290	for
O	2291	2302	identifying
O	2303	2310	persons
O	2311	2313	at
O	2314	2318	high
O	2319	2323	risk
O	2324	2326	of
O	2327	2337	developing
B-Disease	2338	2342	late
I-Disease	2343	2346	ARM
O	2346	2347	.
